Karin J. Metzner

6.7k total citations
102 papers, 2.3k citations indexed

About

Karin J. Metzner is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Karin J. Metzner has authored 102 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Virology, 62 papers in Infectious Diseases and 26 papers in Molecular Biology. Recurrent topics in Karin J. Metzner's work include HIV Research and Treatment (80 papers), HIV/AIDS drug development and treatment (56 papers) and HIV/AIDS Research and Interventions (42 papers). Karin J. Metzner is often cited by papers focused on HIV Research and Treatment (80 papers), HIV/AIDS drug development and treatment (56 papers) and HIV/AIDS Research and Interventions (42 papers). Karin J. Metzner collaborates with scholars based in Switzerland, Germany and United States. Karin J. Metzner's co-authors include Huldrych F. Günthard, Niko Beerenwinkel, Pia Rauch, Volker Röth, Béda Joos, Rainer Weber, Christine Leemann, Francesca Di Giallonardo, Ruth I. Connor and Stephan Scheurer and has published in prestigious journals such as Nucleic Acids Research, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Karin J. Metzner

100 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karin J. Metzner Switzerland 27 1.5k 1.2k 640 365 311 102 2.3k
M. Piatak United States 18 1.3k 0.9× 809 0.7× 614 1.0× 481 1.3× 894 2.9× 22 2.4k
Anthony de Ronde Netherlands 25 1.9k 1.3× 1.3k 1.1× 474 0.7× 483 1.3× 629 2.0× 54 2.4k
Shigeru Kusagawa Japan 22 733 0.5× 756 0.6× 233 0.4× 508 1.4× 172 0.6× 53 1.3k
Evelien M. Bunnik United States 25 790 0.5× 467 0.4× 697 1.1× 376 1.0× 652 2.1× 53 2.0k
Thomas Gramberg Germany 23 1.2k 0.9× 1.3k 1.1× 917 1.4× 759 2.1× 1.3k 4.3× 36 3.2k
Clotilde Thiriart Belgium 18 1.2k 0.8× 567 0.5× 645 1.0× 556 1.5× 660 2.1× 23 2.0k
Robert Parks United States 23 1.0k 0.7× 839 0.7× 675 1.1× 274 0.8× 885 2.8× 45 2.1k
Carmen Gómez Spain 29 1.3k 0.9× 550 0.4× 763 1.2× 892 2.4× 979 3.1× 87 2.5k
K. von der Helm Germany 23 479 0.3× 617 0.5× 626 1.0× 287 0.8× 185 0.6× 62 1.9k
D P Bolognesi United States 20 1.4k 1.0× 662 0.5× 629 1.0× 474 1.3× 925 3.0× 39 2.1k

Countries citing papers authored by Karin J. Metzner

Since Specialization
Citations

This map shows the geographic impact of Karin J. Metzner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin J. Metzner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin J. Metzner more than expected).

Fields of papers citing papers by Karin J. Metzner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin J. Metzner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin J. Metzner. The network helps show where Karin J. Metzner may publish in the future.

Co-authorship network of co-authors of Karin J. Metzner

This figure shows the co-authorship network connecting the top 25 collaborators of Karin J. Metzner. A scholar is included among the top collaborators of Karin J. Metzner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin J. Metzner. Karin J. Metzner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gianella, Sara, Merle Schanz, Roger D. Kouyos, et al.. (2024). Viral and Immune Risk Factors of HIV Rebound After Interruption of Antiretroviral Therapy. The Journal of Infectious Diseases. 231(5). 1221–1229. 2 indexed citations
2.
Fazekas, Dávid, et al.. (2024). Comparative Evaluation of Open-Source Bioinformatics Pipelines for Full-Length Viral Genome Assembly. Viruses. 16(12). 1824–1824. 3 indexed citations
3.
Marinosci, Annalisa, Gilles Wandeler, Sabine Yerly, et al.. (2024). Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy: the SIMPL’HIV open-label, factorial randomised controlled trial. Swiss Medical Weekly. 154(4). 3762–3762. 1 indexed citations
4.
5.
Opitz, Lennart, et al.. (2022). Transcriptome profiles of latently- and reactivated HIV-1 infected primary CD4+ T cells: A pooled data-analysis. Frontiers in Immunology. 13. 915805–915805. 2 indexed citations
6.
Posada-Céspedes, Susana, David Seifert, Ivan Topolsky, et al.. (2021). V-pipe: a computational pipeline for assessing viral genetic diversity from high-throughput data. Bioinformatics. 37(12). 1673–1680. 46 indexed citations
7.
Lejone, Thabo Ishmael, Isaac Ringera, Thomas Klimkait, et al.. (2021). Emergence of Human Immunodeficiency Virus-1 Drug Resistance During the 3-Month World Health Organization-Recommended Enhanced Adherence Counseling Period in the CART-1 Cohort Study. Open Forum Infectious Diseases. 8(5). ofab046–ofab046. 1 indexed citations
8.
Neumann, Kathrin, et al.. (2020). HIV-1 promoter is gradually silenced when integrated into BACH2 in Jurkat T-cells. PeerJ. 8. e10321–e10321. 3 indexed citations
9.
Wandeler, Gilles, Sabine Yerly, Annalisa Marinosci, et al.. (2020). Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL’HIV trial. PLoS Medicine. 17(11). e1003421–e1003421. 20 indexed citations
10.
11.
Aebi‐Popp, Karoline, Gilles Wandeler, Luisa Salazar‐Vizcaya, et al.. (2018). Rapid decline of anti‐hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV‐infected men who have sex with men. HIV Medicine. 19(6). 420–425. 13 indexed citations
12.
Rusert, Peter, Carsten Magnus, Claus Kadelka, et al.. (2017). Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality. PLoS Pathogens. 13(3). e1006255–e1006255. 26 indexed citations
13.
Vongrad, Valentina, Jochen Imig, Pejman Mohammadi, et al.. (2015). HIV-1 RNAs are Not Part of the Argonaute 2 Associated RNA Interference Pathway in Macrophages. PLoS ONE. 10(7). e0132127–e0132127. 14 indexed citations
14.
Giallonardo, Francesca Di, Armin Töpfer, Sandhya Prabhakaran, et al.. (2014). Full-length haplotype reconstruction to infer the structure of heterogeneous virus populations. Nucleic Acids Research. 42(14). e115–e115. 89 indexed citations
15.
Metzner, Karin J., Alexandra Scherrer, Viktor von Wyl, et al.. (2014). Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients. AIDS. 28(15). 2231–2239. 20 indexed citations
16.
Prabhakaran, Sandhya, et al.. (2013). Recovering networks from distance data. Machine Learning. 92(2-3). 251–283. 2 indexed citations
17.
Metzner, Karin J., Christine Leemann, Francesca Di Giallonardo, et al.. (2011). Reappearance of Minority K103N HIV-1 Variants after Interruption of ART Initiated during Primary HIV-1 Infection. PLoS ONE. 6(7). e21734–e21734. 8 indexed citations
18.
Rieder, P., Béda Joos, Alexandra Scherrer, et al.. (2011). Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection. Clinical Infectious Diseases. 53(12). 1271–1279. 64 indexed citations
19.
Metzner, Karin J., James Μ. Binley, Agegnehu Gettie, et al.. (2006). Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques. Retrovirology. 3(1). 97–97. 13 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Piatak Breakdown of academic impact, for papers by Anthony de Ronde Breakdown of academic impact, for papers by Shigeru Kusagawa Breakdown of academic impact, for papers by Evelien M. Bunnik Breakdown of academic impact, for papers by Thomas Gramberg Breakdown of academic impact, for papers by Clotilde Thiriart Breakdown of academic impact, for papers by Robert Parks Breakdown of academic impact, for papers by Carmen Gómez Breakdown of academic impact, for papers by K. von der Helm Breakdown of academic impact, for papers by D P Bolognesi
Rankless by CCL
2026